Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery IV, Peking University Cancer Hospital and Institute, 52 Fu-Cheng Road, Hai-Dian District, Beijing, 100142, China.
Clin Transl Oncol. 2021 Feb;23(2):335-343. doi: 10.1007/s12094-020-02426-3. Epub 2020 Jun 26.
Multiple primary colorectal cancers (MPCCs) are different from solitary colorectal cancers in many aspects, which are not well studied. The aim of this study was to clarify the clinicopathological features and prognosis of MPCCs.
The data of 64 patients with MPCCs out of 2300 patients with colorectal cancers (CRCs) from January 2009 to December 2017 were retrospectively analyzed. Stratified analysis was conducted based on subtypes and microsatellite status.
The overall incidence of MPCC was 2.8% and the median follow-up duration was 51.5 (range 1-120) months. Metachronous CRCs (MCRCs) are more likely to appear in the right colon (p < 0.05). However, no significant differences regarding age, sex, BMI, tumor size, smoking/drinking history, TNM stage, family history of cancer, and 5-year survival rate were observed between synchronous CRC (SCRC) and MCRC. Advanced TNM stage (III) and the presence of polyps were found to be independent poor prognostic factors for MPCCs. The prevalence of mismatch repair deficiency (dMMR) in MPCCs was 28.1%. Deficient MMR is more likely to appear in younger, lighter MPCC patients with polyps (p < 0.05). Of four mismatch repair proteins, MLH-1, MSH-2, MSH-6, and PMS-2 were negative in nine, nine, five, and nine patients, respectively. The 5-year survival rate did not differ significantly between MMR-proficient (pMMR) and dMMR groups (p = 0.752).
Synchronous CRC (SCRC) and MCRC might represent similar disease entities with different courses. Deficient MMR is more likely to appear in younger, lighter MPCC patients with polyps and it is an essential indicator for screening Lynch syndrome.
多发性原发性结直肠癌(MPCC)在许多方面与单发结直肠癌不同,但目前对其研究尚不充分。本研究旨在阐明 MPCC 的临床病理特征和预后。
回顾性分析了 2009 年 1 月至 2017 年 12 月期间 2300 例结直肠癌(CRC)患者中 64 例 MPCC 患者的数据。根据亚型和微卫星状态进行分层分析。
MPCC 的总体发生率为 2.8%,中位随访时间为 51.5(范围 1-120)个月。右半结肠更易出现异时性 CRC(MCRC)(p<0.05)。然而,SCRC 和 MCRC 之间在年龄、性别、BMI、肿瘤大小、吸烟/饮酒史、TNM 分期、癌症家族史和 5 年生存率方面无显著差异。晚期 TNM 分期(III 期)和息肉存在被发现是 MPCC 的独立不良预后因素。MPCC 中错配修复缺陷(dMMR)的发生率为 28.1%。在存在息肉的年轻、较轻的 MPCC 患者中,dMMR 更常见(p<0.05)。在四个错配修复蛋白中,MLH-1、MSH-2、MSH-6 和 PMS-2 分别有 9、9、5 和 9 例患者呈阴性。pMMR 组和 dMMR 组的 5 年生存率无显著差异(p=0.752)。
SCRC 和 MCRC 可能代表具有不同病程的相似疾病实体。dMMR 更可能出现在年轻、较轻的伴有息肉的 MPCC 患者中,它是筛查 Lynch 综合征的重要指标。